Andy Kistler, MD, PharmD, Author at Gastroenterology Advisor

Is Prophylactic Clipping Effective in Preventing Post-Polypectomy Bleeding?

By

June 12, 2020

Researchers conducted a meta-analysis to evaluate prophylactic clipping in preventing post-polypectomy bleeding and published the results in Gastroenterology.

Inflammatory Bowel Diseases (IBD)

Dual Biologic Therapy in Crohn Disease: A New Treatment Paradigm?

By

Andy Kistler, MD, PharmD

June 2, 2020

There is significant interest in optimizing medical treatments of Crohn’s disease (CD) in hopes of preventing complications and the need for surgery.

General Gastroenterology

COVID-19: Atypical GI Presentations

By

Andy Kistler, MD, PharmD

May 18, 2020

There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.

Inflammatory Bowel Diseases (IBD)

Ulcerative Colitis and Fecal Transplantation: Where are We Now?

By

Andy Kistler, MD, PharmD

April 30, 2020

It is thought that dysregulation of the gut microbiome could cause increased production of pro-inflammatory toxins that can predispose patients to the development of UC.

General Gastroenterology

AGA Guidelines Regarding GI Procedures During the COVID-19 Pandemic

By

Andy Kistler, MD, PharmD

April 10, 2020

An area that has been specifically challenging within gastroenterology is the management of how and when to perform GI procedures, especially when many patients with COVID-19 have gastrointestinal (GI) symptoms.

Esophagus

Barrett Esophagus Recurrence After Complete Eradication of Intestinal Metaplasia

By

Andy Kistler, MD, PharmD

April 6, 2020

Surveillance recommendations are based on the initial grade of dysplasia.

Inflammatory Bowel Diseases (IBD)

Etrasimod in Ulcerative Colitis: Promising Phase 2 Results

By

Andy Kistler, MD, PharmD

April 3, 2020

Researchers evaluated the efficacy and safety of etrasimod, an oral, selective sphingosine 1-phosphate receptor modulator in development for immune-mediated inflammatory disorders, in patients with moderate to severe ulcerative colitis.

Colorectal neoplasia

AF and Anticoagulation: Consider CRC in Patients With Lower GI Bleeding

By

Andy Kistler, MD, PharmD

April 2, 2020

The absolute 1-year risk of colorectal cancer in patients with atrial fibrillation treated with oral anticoagulants is not trivial.

General Gastroenterology

COVID-19: Symptoms and Laboratory Findings Gastroenterologists Need to Know

By

Andy Kistler, MD, PharmD

March 30, 2020

Although patients with COVID-19 are known to present with constitutional and respiratory symptoms such as fever, cough, sore throat, and shortness of breath, there is growing evidence that these patients can also experience significant gastrointestinal symptoms such as nausea, vomiting, and diarrhea.